跳至主要内容
临床试验/NL-OMON50559
NL-OMON50559已完成不适用

Detection of circulating tumour cells in cerebrospinal fluid (CSFCTs) to diagnose leptomeningeal metastases (LM) among breast cancer patients - CTCs in liquor

Erasmus MC, Universitair Medisch Centrum Rotterdam0 个研究点目标入组 96 人开始时间: 待定最近更新:

试验速览

阶段
不适用
状态
已完成
入组人数
96

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • Study population:
  • - Breast cancer patients with clinical suspicion of LM who are planned to
  • undergo a LP to confirm/exclude the diagnosis LM
  • - Signed informed consent, Control Group:
  • - Patients with a hematologic malignancy, who are planned to undergo a LP for
  • CSF analysis to confirm or to exclude the diagnosis LM, will be included as
  • negative controls.
  • - Signed informed consent.

排除标准

  • Study Population:
  • - Contra-indication for LP (on the discretion of the treating neurologist),
  • Control Group:
  • - Contra-indication for LP (on the discretion of the treating neurologist)
  • - A medical history of a solid malignancy.

研究者

相似试验